Guidance on injection technique for retatrutide is extrapolated from established subcutaneous injectable therapies such as semaglutide (Wegovy/Ozempic) and tirzepatide (Mounjaro), which share a similar administration route
Energy and Fatigue Fatigue during the dose escalation phase was reported by roughly 10% of women and 8% of men
These werent marginal improvements either
Studies are still happening to understand why. The data from Dandelion Health showed that the 10% of people with the best response to GLP-1s had results that mirrored what clinical trials found, but the 10% with the least success with the treatments had no weight change, or even an increase in weight, over time
Shift toward non-daily dosing and non-injectable routes: weekly injectables, oral tablets and pipeline transdermal/patch approaches are reducing treatment burden
We are conveniently located at 5748 N Canton Center Rd, Canton Township, MI 48187